Abe Michiko, Ide Kentaro, Nishimura Nao, Nakagawa Satoshi, Fukuda Akinari, Sakamoto Seisuke, Kasahara Mureo
Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan.
Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.
Pediatr Transplant. 2017 Dec;21(8). doi: 10.1111/petr.13063. Epub 2017 Sep 12.
Refractory septic shock after LT is a life-threatening complication. VA ECMO is used to treat refractory cardiorespiratory failure. We present herein the case of a 5-year-old girl with post-Kasai biliary atresia, who underwent a living donor LT and suffered refractory septic shock. VA ECMO was indicated due to progressive cardiac deterioration. After full recovery of her EF, she has been steadily improving and has shown good liver function and no neurological sequelae. This is the first report of successful VA ECMO in a post- LT patient with refractory septic shock.
肝移植后难治性感染性休克是一种危及生命的并发症。静脉-动脉体外膜肺氧合(VA ECMO)用于治疗难治性心肺衰竭。我们在此报告一例5岁患有葛西手术后胆道闭锁的女孩,她接受了活体供肝肝移植并发生难治性感染性休克。由于心脏功能进行性恶化,遂使用VA ECMO。在其射血分数完全恢复后,她病情稳步改善,肝功能良好且无神经后遗症。这是首例关于VA ECMO成功应用于肝移植后难治性感染性休克患者的报告。